Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Docebo (DCBO) Other Operating Expenses (2021 - 2025)

Historic Other Operating Expenses for Docebo (DCBO) over the last 5 years, with Q2 2025 value amounting to $4000.0.

  • Docebo's Other Operating Expenses rose 11379.31% to $4000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $19.1 million, marking a year-over-year decrease of 5454.35%. This contributed to the annual value of $77.8 million for FY2024, which is 11.29% down from last year.
  • As of Q2 2025, Docebo's Other Operating Expenses stood at $4000.0, which was up 11379.31% from $19.1 million recorded in Q4 2024.
  • Over the past 5 years, Docebo's Other Operating Expenses peaked at $21.4 million during Q4 2023, and registered a low of -$29000.0 during Q2 2024.
  • In the last 5 years, Docebo's Other Operating Expenses had a median value of $12.9 million in 2021 and averaged $10.0 million.
  • In the last 5 years, Docebo's Other Operating Expenses plummeted by 9992.5% in 2022 and then soared by 11379.31% in 2025.
  • Quarter analysis of 5 years shows Docebo's Other Operating Expenses stood at $13.8 million in 2021, then rose by 28.41% to $17.8 million in 2022, then increased by 20.24% to $21.4 million in 2023, then dropped by 10.48% to $19.1 million in 2024, then plummeted by 99.98% to $4000.0 in 2025.
  • Its Other Operating Expenses was $4000.0 in Q2 2025, compared to $19.1 million in Q4 2024 and $20.7 million in Q3 2024.